8
Herein, various ambiguous aspects of the immune system that 9 render this complex biological network so highly flexible and 10 able to defend the host from persisting infections such as that 11 induced by the hepatitis C virus (HCV) are reviewed. This ambi-12 guity stems mainly from the property of the immune system to 13 be both protective and harmful. Immunity cannot be fully protec-14 tive without producing a certain degree of damage (acute hepati-15 tis resulting in resolving HCV infection). In addition, the balance 16 between protection and tissue damage is critical for the develop-17 ment of chronic HCV infection. The establishment of a state of 18 chronic low-level inflammation is instrumental to limit liver 19 immunopathology, to limit viral spread, and ultimately to ensure 20 a long-lasting survival of the host. It is dictated by a fine equilib-21 rium maintained by multiple immunologic mechanisms, includ-22 ing: sensory perception of innate immunity, virus-specific T and 23 B cell functions, control of immune responses, and finally the bal-24
ance between immunity and immunopathology that has princi-25 pally evolved to favor the species survival.
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Introduction Q2 31 Hepatitis C virus (HCV) is a positive-stranded RNA virus belong-32 ing to the Flaviviridae family (reviewed in [1] ). HCV eludes host 33 defenses in a considerable portion of infected individuals, devel-34 oping a status of viral persistence, representing the major cause 35 of chronic hepatitis, cirrhosis, and hepatocellular carcinoma 36 (reviewed in [1] [2] [3] ). This review considers the various mecha-37 nisms of HCV persistence, and mainly concentrates on those by 38 which T cell responses have been evolved to favor long-term host 39 survival, in spite of chronic HCV-dependent liver disease. Immune activities in resolving HCV infection. Innate immunity can be principally affected by HCV at the level of both type I IFN production by infected hepatocytes and the signals provided by the relative receptors (IFNAR-1/2) once they are engaged by soluble type I IFNs (mainly produced by pDCs). If these defects are combined with low viral load or infection by HCV strains that are highly susceptible to antiviral IFN effects, HCV viral spread would be contained, and the functions by DCs, NK, B, and T cells should not be heavily affected. This possibility might account for the evidence that the HCV-specific CD4 T cells efficiently differentiate into protective T EM (with Th1 phenotype) and T CM cells, despite the fact that HCV-specific CD8 T EM cells that result are dysfunctional. Since DCs are not susceptible to HCV infection, they could activate CD8 T cells through the phenomenon of cross-presentation of apoptotic hepatocyte bodies containing HCV products. This phenomenon might not be enough to induce efficient primary or secondary CD8 T cell responses, in the absence of direct HCV presentation by infected DCs. In addition, HCV-specific PD-1 + CD8 T cells (simultaneously recognizing MHC class I/viral epitope complexes and PD-L1 on infected hepatocytes) should acquire an exhausted/dysfunctional phenotype in the site of infection, more than PD-1 + CD4 cells. CD4 T cells might guarantee resolution, by producing protective cytokines, helping antigen-specific B cells, and finally sparing some virus-specific CD8 cells from becoming dysfunctional. Under these conditions, the negative loop leading to T cell exhaustion by the interaction between PD-1 expressed on activated T cells and PD-L1 expressed on all lymphoid and non-lymphoid cells would have the ability to switch off unwanted responses, once the virus has been cleared. 3] ). Therefore, we favor the 149 hypothesis that HCV does not interfere with the pDC functions, 150 but it makes infected hepatocytes non-susceptible to the high 151 levels of circulating pDC-derived type I IFNs, because of its capac-152 ity to affect the signals triggered by their own specific type I IFN 153 receptors ( Fig. 1) .
154 The second fundamental DC population in humans is consti-155 tuted by cDCs deriving from the myeloid lineage [17, 18] . Given 156 the critical role of cDCs in priming T cell responses (see Box 1), 157 they have been extensively studied in HCV infection, with the 158 idea that HCV-mediated inhibition of cDC functions could result 159 in inefficient antiviral T cell responses. Contrasting evidence 160 resulted from these analyses. cDCs from chronically-infected 161 individuals have not been found to be numerically decreased in 162 the peripheral blood or even dysfunctional in vitro in terms of 163 pro-inflammatory or antigen-presentation capacities, in all stud-164 ies or patients [19, 20] . As well as in the case of pDC studies, the 165 relevance of both the analysis on circulating cDCs from patients, 166 and those showing the capability of some recombinant HCV pro-167 teins to affect the functions of normal cDCs in vitro [21, 22] , is 168 strongly restrained by the evidence that chronically-infected 169 individuals are not globally immuno-compromised. In vivo mod-170 els of HCV infection are required to determine the possibility of a 171 selective impairment of DCs or HCV-specific T cells infiltrating 172 HCV-infected livers due to the high concentrations of viral pro-173 teins produced in the site of infection. The selective dysfunction cDCs prime T cell responses, upon the processing and presentation of exogenous antigens, which are preferentially presented on major histocompatibility complex (MHC) class II molecules, or endogenous antigens, which vice-versa are preferentially presented on MHC class I molecules. However, the capacity of cDCs to present exogenous antigens derived from other cells (usually necrotic or apoptotic cells) or soluble antigens class I molecules is defined as cross-presentation [50-53]. The main model of cross-presentation suggests that it requires cytosolic proteasomes,the transporter associated with antigen processing (TAP) the loading of the resulting peptides of the class I molecules in either the endoplasmic reticulum (ER) or directly in the phagosomes upon reimport by phagosomal TAP, but the precise mechanisms involved still remains controversial. All tissues are "patrolled" by cDCs that, like bifacial Janus, can perform opposing (tolerogenic or stimulatory) functions, according to the context in which they work [17, 18] . In an inflammatory context (mainly induced by infectious agents), cDCs are activated (for instance, through PRRs engagement by PAMPS or DAMPS), efficiently internalize antigens [86] , produce various inflammatory cytokines, and increase the expression of stimulatory (signal 1) and costimulatory (signal 2) molecules [17, 18] . In addition, they upregulate the lymph node-specific chemokine receptors (Cys-Cys chemokine receptor 7 [CCR7]), and thus, acquire a strong capacity to migrate into the lymph nodes, where they can prime naïve (CCR7 -CD26L + ) CD4 or CD8 T lymphocytes specific to the antigens that have been internalized in the inflamed tissue, and promote their differentiation into two distinct subpopulations, the effector memory(CCR7 -CD26L -) T(T EM ) and the central memory (CCR7 + CD26L + ) T (T CM ) lymphocytes [87] . T EM cells migrate to the inflamed tissues because of the newly acquired expression of tissue-specific chemokine receptors [88] . According to the microenvironmental context, lymphocytes are polarised towards different types of effector capacities that can provide opposing protective and harmful effects (Fig.2) . In the case of intracellular pathogen infections (e.g. viral infections), cDCs produce IL-12, and in the presence of IFN-γ, CD4 or CD8 T cell priming is skewed towards the polarization of either proinflammatory T helper (Th)1 cells or CD8+ T cells with high cytototoxic potential, respectively: these cells will simultaneously provide protective responses against intracellular pathogens and harmful responses via their immunopathological activities [89] . Under conditions (bacterial, fungal, or viral infections) in which cDCs are stimulated to produce IL-23 (another member of the IL-12 family), and in the presence of IL-6, transforming growth factor (TGF)-β and IL-1, T cells differentiate towards Th17 cells (producing IL-17), described to provide protection against some extra-or intracellular pathogens, but to be also responsible for causing severe autoimmune disorders [90] [91] [92] . In the presence of IL-4, naïveT cells preferentially differentiated into Th2 (producing IL-4, IL-5, IL-13...) with protective responses against extracelllular pathogens or harmful responses in the case of allergic reactions [93] . Sustained stimulation by DCs is also critical for priming T CM cells that are trapped in the lymphoid tissues, where they remain numerically constant, because of the expression of receptors specific for the homeostatic (IL-7 and IL-15) cytokines [27, 28] .
of liver-infiltrating DCs or T cells might result relevant by pro-175
foundly affecting the adaptive immune responses against HCV 176 at the level of the infection site (Fig. 2) . [27] . These mechanisms guarantee 207 the prompt emergence of high frequencies of competent effector Fig. 2 . Immune dysfunctions related to chronic HCV infection. High viral load and/or infection by HCV strains that are not susceptible to antiviral effects of endogenous type I IFNs, facilitating HCV viral spread, might strongly affect the function of DCs, NK, B, and T cells. The misfunction of CD4 and CD8 T cells will result in inefficient effector and memory responses and will result in the development of a state of viral persistence. This would also be conditioned by the emergence of several, non-mutually exclusive factors, such as viral epitope escape, viral subversion, the host immunological mechanisms (PD-1, Treg cells, etc.) addressed to control immunopathology, at the cost of the acquiring side-effects that limit protection. Under these conditions, a state of chronic low-level inflammation will take place and will be instrumental in limiting liver immunopathology, viral spread, and finally to ensure long-lasting survival of the host.
T cells that are essential for recovery. Upon infection resolution, 209 effector cells disappear, whereas memory cells remain numeri-210 cally constant because of the expression of receptors specific 211 for the homeostatic (IL-7 and IL-15) cytokines [28] . The homeo-212 static proliferation of memory cells in the absence of antigen, is 213 critical for prompt differentiation into effector cells, should they 214 re-encounter the original infecting pathogen.
215
The immunologic scenario promoting infection resolution is 216 only partially respected in acute HCV infection. However, the 217 common conviction that HCV induces chronic infection in the 218 majority of infected individuals has been challenged by the 219 observation that T cells against multiple HCV epitopes persist 220 in a considerable proportion of healthy (non-infected) individuals 221 accidentally exposed to HCV [29, 30] . This data strongly suggests 222 that recovery from asymptomatic form of HCV infection, and that 223 the generation of efficient virus-specific T cell responses clearing 224 HCV are far more frequent than commonly believed [31] .
225

HCV-specific B and T cell responses
226
The finding that agammaglobulinemic patients can resolve acute 227 HCV infection upon IFN-a treatment, leads to the hypothesis that 228
HCV-specific T cells may compensate for the lack of neutralizing 229
antibodies to obtain HCV clearance [32] . However, recent data 230
suggested that the prompt emergence of neutralizing antibodies 231 in the early phases of infection could play a major role in clearing 232 HCV in immunocompetent patients. Indeed, they have been 233 detected at high levels both during the early phase of infection 234 in association with spontaneous resolution of HCV [32] , and once 235 chronic HCV infection is established (reviewed in [1] (Fig. 2) , suggesting hence that the 272 simultaneous dysfunctions of both CD8 and CD4 cells are associ-273 ated with disease progression in the majority of infected individ-274 uals. Thus, the combination of functional HCV-specific CD4 and 275 CD8 T cells obviously should be the right recipe for recovery, as 276 it is in resolving flu, CMV, or EBV infections. This scenario may 277 contribute to HCV clearance in a considerable proportion of 278 asymptomatic infected individuals, which have been exposed to 279 a different source of HCV infection [29] [30] [31] . Another aspect to 280 consider is the possibility that other T cell subsets or functions 281 may intervene in dictating the fate of HCV infection. In this con-282 text, the role of HCV-specific T (CD4 and/or CD8) cells with a 283 Th17 profile in HCV protection, chronic evolution, or pathogene-284 sis is an important topic requiring more in-depth investigations 285 [47]. Indeed, it has been recently reported that Th17 cells play 286 a key role in establishing chronic viral infections [48, 49] . In the 287 following section, the possible mechanisms that may affect the 288 HCV-specific adaptive immune response will be analyzed.
289
Mechanisms affecting adaptive immune cells in acute HCV infection
290
The mechanism of cross-presentation 291 It would be relevant to determine if the selective impairment of 292 HCV-specific CD8 T cell responses may be related to the observa-293 tion that DCs are not susceptible to HCV infection, and thus in 294 principle, they cannot process endogenous HCV antigens and 295 directly present the resulting epitopes on class I molecules 296 [3, 13, 14] . As a result, HCV-specific CD8 T cells might be primed 297 only via the mechanism of cross-presentation (see Box 1). In 298 cross-presentation, non-infected DCs capture exogenous HCV 299 antigens or apoptotic liver cells carrying HCV and then cross-300 present the related HCV epitopes on class I molecules [50-53] 301 (Fig. 1) . This mechanism might not be enough to prime efficient 302 CD8 T cell responses (See Box 2 Q5 ).
The immune system has evolved to simultaneously perform different strategies that appear opposite but eventually result in an evolutionary advantage. On the one hand, the immune responses contribute to the species survival, on the other hand it can lead to the sacrifice of single individuals. During the evolutionary process, the selective pressure led to the generation of multiple ambiguous mechanisms to better counteract the aggression of infectious agents. This is the case of the immune system strategies addressed to contain the aggression of HCV and to limit the related liver damages. Following the establishment of the HCV persistence, the long-term host survival can be obtained only through the capacity of the immune system to establish a good relationship with the virus. This take place via a complex series of homeostatic mechanisms that condition the establishment of chronic low-level immune responses, resulting in the control of the viral spread and to limit excessive liver damage. Although this is obtained at the cost of severe side effects (tumors, autoimmune diseases...) in some individuals, these side effects are considered irrelevant in terms of the survival of the species. infection resolution, despite dysfunctional HCV-specific CD8 T 321 cells (Fig. 1) . Otherwise, the lack of functionally competent 322 HCV-specific CD4, associated with exhausted CD8 T cells, would 323 unavoidably lead towards chronic infection in the majority of 324 patients (Fig. 2) . etc.) addressed to control immunopathology, at the cost of the 331 side effect of limiting protection. All these factors will induce 332 the generation of non-protective virus-specific CD4 and CD8 T 333 cells, which might even become harmful (Fig. 2) .
PD-1/PD-L1 interaction
334
Viral mutations 335
HCV's strong capability to mutate B or T cell epitopes and possi-336 bly to escape related responses at several levels (antigen process-337 ing, MHC binding, TCR or BCR recognition, etc.) is due to its high 338 replication rate and the lack of proofreading capacity of its poly-339 merase (reviewed in [1] 
362
Regulatory cytokines
363 A recent report demonstrated that peripheral HCV-specific CD4 364 and CD8 T cells producing IL-10 are detectable in the early phases 365 of acute HCV infection [64] . These cells seem to suppress antiviral 366 effector responses, promoting chronic evolution of infection, 367 while limiting progressive liver damage [64] . These suggestions 368 are reminiscent of our previous studies showing that IL-10 pro-369 ducing HCV-specific CD8 T cells infiltrate the liver of chroni-370 cally-infected individuals [65] . They inversely correlated with 371 both the frequency of HCV-specific T cells producing IFN-c and 372 the inflammatory staging at the level of liver biopsies, suggesting 373 that they modulate excessive liver immunopathology [65] . 374 Accordingly, it has been reported that intrahepatic HCV-specific 375 IL-10 producing CD8 T cells prevent liver damage during chronic 376 infection [66] . TGF-b-producing virus-specific CD4 and CD8 T 377 cells have been related to antiviral immune suppression and 378 chronic HCV infection evolution [67] . Taken together, these data 379 suggest that regulatory cytokines such as IL-10 or TGF-b mini-380 mize liver inflammation, at the cost of the protective immune 381 responses clearing the virus (Fig. 2) . 394 ongoing protective immune responses once they are no longer 395 necessary or become harmful after the elimination of the patho-396 gen and (c) to limit excessive immunopathology during chronic 397 inflammatory diseases. As a result of the expression of the Il-2 398 gene-inhibitory Foxp3 transcription factor, Treg cells do not pro-399 duce IL-2 and are unable to respond to antigens (anergy) [72, 73] . 400 However, Foxp3 activity maintains high levels of IL-2 receptors 401 (CD25 hi ) on Treg cells, hence compensating for the incapacity of 402 producing IL-2. Indisputably, CD25
hi Treg cells promptly prolifer-403 ate both in vitro and in vivo in response to relevant antigens in the 404 presence of paracrine IL-2, which is mainly produced by respon-405 der (effector) T-lymphocytes, but it is dominantly absorbed by 406 Treg cells expressing higher CD25 levels than responder T cells 407 [74] [75] [76] . This appears to represent a key suppression mechanism, 408 because CD25
hi Treg cells steal the majority of IL-2 produced by 409 responder T cells that in turn will be deprived of their most 410 important growth factor. Furthermore, Treg cells suppress via dif-411 ferent, likely non-mutually exclusive mechanisms, involving 412 membrane molecules (such as cytotoxic T-lymphocyte antigen-413 4 or adenosine receptors) and suppressive cytokine production 414 (such as TGF-b or IL-10) [68] [69] [70] [71] . Treg cells are induced and pro-415 liferate in response to HCV and seem to modulate liver inflamma-416 tion in the course of chronic infection [77, 78] . Therefore, the 417 model of HCV infection supports the idea that Treg cells partici-418 pate in the establishment of a fine equilibrium between immuno-419 pathology and immune protection, ultimately resulting in the 420 long-lasting survival of the host during chronic infections 421 [69, 70, [79] [80] [81] [82] [83] (Fig. 2) (Fig. 3) . This may represent a critical contra-suppression mecha-449 nism that has evolved to assure that Treg cells have limited 450 suppression. Homeostatic balance participates in establishing a 451 status of chronic low-level liver inflammation that is in turn 452 instrumental to ensure long-lasting survival of the host.
Conclusions
454
Through the different (non-mutually exclusive) mechanisms 455 illustrated above, the host survives for a long time in parallel with 456 both the persistent HCV infection and a low-grade liver inflam-457 mation that can degenerate into liver failure after several dec-458 ades. The ambiguous co-existence of virus and inflammation 459 results in an advantage for the evolutionary process and hence 460 for human species survival. If immune responses were invariantly 461 strong and aggressive during a persistent infection such as HCV, 462 they would be unable to eliminate that infection, because of its 463 acquired capacity to escape or to subvert them. In such a situa-464 tion, exuberant (but non-protective) responses would produce 465 prompt irreversible tissue (hepatic failure) damage, leading to 466 catastrophic epidemic infections. Considering this point of view, 467 chronic (low-level) inflammatory diseases seem to represent a 468 sort of safeguard for the human survival. We can assume that 469 chronic inflammation may be defined as the ''Yin and Yang" of 470 the immune system. On the one hand, it guarantees the long-471 term survival of human hosts despite pathogen persistence. On 472 the other hand, the imbalance of the homeostatic mechanisms 473 maintaining chronic inflammation may degenerate into severe 474 ''side-effects" (i.e., the development of either autoimmune dis-475 eases or tumours) in a minority of infected individuals. From an 476 evolutionary point of view, the onset of autoimmune diseases 477 or the development of some tumours might be the price to pay 478 following the establishment of chronic inflammation. Indeed, a 479 status of pre-existing chronic inflammation can contribute to 480 the development of cancer, by the production of growth and 481 angiogenic factors eventually promoting cancer-cell survival, 482 implantation, and growth. In addition, chronic inflammation 483 can affect the immune-surveillance directly via its own intrinsic 484 mechanisms (i.e., expansion of Treg cells, T cell exhaustion, 485 etc.), and indirectly by the incapacity to limit the immunosup-486 pressive effects of tumours. The production of soluble factors 487 (i.e., pro-inflammatory or cell growth cytokines) that favor cell 488 proliferation, generally needed for the immune system to defend 489 the host efficaciously, can also facilitate the mitotic cycle of non-490 lymphoid cells. In the long run, this prolonged stimulation can 491 induce, as in the case of liver cirrhosis by both HBV and HCV, 492 necrosis, cell renewal, and even neoplastic transformation [84] . 
